CAS 112809-51-5 Anti Estrogen Steroid Powder White Henlthy Letrozole Femara for Breast Cancer
Iinkcukacha eziKhawulezayo
CAS: 112809-51-5
Izithethantonye:FEMARA;CGS-20267;LETROZOL;LETROZOLE;LetrozoleUsp28;Letrozole99%;CGS-20267, Femara
Ubunyulu:99%
Imbonakalo:Ikristale emhlophe okanye etyheli
Ifomula yemolekyuli: C17H11N5
Ubunzima beMolekyuli: 285.31
Indawo yokunyibilika: 181°C–183°C
I-Anti Estrogen Ukwakhiwa Komzimba Iisteroids Letrozole Femara White Powder CAS 112809-51-5
Ukusetyenziswa: Isetyenziswe njenge-API kuNyango lwesifo sebele.
I-dose ephakanyisiweyo ye-Femara yi-tablet enye ye-2.5 mg elawulwa kanye ngosuku, ngaphandle kokutya.
I-Letrozole yehlisa amanqanaba e-estrogen kubasetyhini be-postmenopausal, enokuthi icothise ukukhula kweentlobo ezithile zamathumba amabele afuna i-estrogen ukuze ikhule emzimbeni.
Iresiphi yeLetrozole
| umthamo | impahla |
| 1 igram | I-Letrozole powder |
| 19.9 ml | IPG 300 |
| 179.1 ml | 190 Ubungqina bobuNkozo botywala |
I-Letrozole / i-Femara Dosing
Abasebenzisi be-Anecdotally baye babika ukubona iziphumo ezilungileyo besebenzisa amanani avela malunga ne-.25mgs ngosuku ukuya kwi-.5mgs ngosuku.Nangona kunjalo la mayeza ayahluka ngokubanzi ukusuka kumsebenzisi ukuya kumsebenzisi, kubandakanywa iishedyuli zedosi.Abanye baye baxela ukusebenzisa ikhompawundi yonke imihla okanye yonke imihla yesithathu ngemiphumo emihle.Kwakhona, iidosi ezixeliweyo ziye zahluka ukusuka kwi-.25mgs ukuya kuthi ga kwi-2.5mgs ngosuku.
Malunga ne-dosing, kufuneka wenze ukhetho ngokudibeneyo nemeko yomzimba wakho, okanye udibane nomqeqeshi / ugqirha wakho.Eli nqaku lenzelwe ireferensi kuphela.
I-Letrozole / i-Femara Effect
I-Letrozole kwizigulana ze-postmenopausal ezinomhlaza webele ophezulu one-Estrogen receptor kunye / okanye i-progesterone receptor positive okanye imeko ye-receptor engaziwayo
I-Femara (i-letrozole) luhlobo lwe-II (non-steroidal) lwesizukulwana sesithathu se-aromatase inhibitor.Ngokweklinikhi isetyenziselwa ukunyanga abasetyhini abasemva kokuya exesheni kunye nokuba yi-estrogen receptor positive okanye i-estrogen receptor engaziwayo yomhlaza wamabele.
1. I-Letrozole yi-Aromatase Inhibitor enamandla eyaphuhliswa ukulwa nomhlaza webele.
2. Kubadlali kunye nabakhi bomzimba, isilwanyana esisetyenziselwa ukulwa ne-estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia.
3. Kwakhona kuya kuphakamisa amanqanaba e-testosterone ngenxa ye-estrogen ephantsi emzimbeni.
4. I-Femara(igama eliqhelekileyo yi-letrozole) lichiza elitsha elenzelwe ukunyanga umhlaza wamabele okwinqanaba eliphezulu kwabasetyhini.
5. I-Femara yeyesibini kwiklasi entsha yesizukulwana sesithathu esikhethiweyo somlomo we-aromatase inhibitors.
6. Isebenza ngokuthintela i-enzyme aromatase, emva koko ivalela ukuveliswa kwe-estrogen.
Inkcazo yeLetrozole/Femara
Kwesinye isifundo sovavanyo lwendoda uLetrozole wakwazi ukunciphisa amanqanaba e-estrogen kumanqanaba angabonakaliyo.I-Letrozole iyakwazi ukuphakamisa i-testosterone kwizifundo zamadoda.
I-Letrozole (i-Femara) isetyenziselwa ukunyanga umhlaza webele kubasetyhini be-postmenopausal.I-Letrozole idla ngokunikezelwa kwabasetyhini abaye bathatha i-tamoxifen (i-Nolvadex, i-Soltamox) iminyaka eyi-5.I-Letrozole i-non-steroidal aromatase inhibitor (inciphisa imveliso ye-estrogen).
I-Letrozole ifumaneka kwifom yegeneric.Iziphumo eziqhelekileyo ezichaphazelekayo ziquka ukutshisa okutshisa, ukulahleka kweenwele, intlungu edibeneyo / ithambo / imisipha, ukudinwa, ukubila okungaqhelekanga, isicaphucaphu, isifo sohudo, isiyezi, kunye neengxaki zokulala.
I-dose ephakanyisiweyo ye-Letrozole yi-tablet ye-2.5 mg elawulwa kanye ngosuku, ngaphandle kokutya.
Amanye amachiza anokunxibelelana neLetrozole.Xelela ugqirha wakho yonke imiyalelo kagqirha kunye namayeza angaphaya kwe-counter-the-counter kunye nezongezelelo ozisebenzisayo.I-Letrozole akufuneki isetyenziswe ngexesha lokukhulelwa.I-Letrozole inokwenzakalisa umntwana ongekazalwa.
I-Letrozole isetyenziswa ikakhulu kubasetyhini emva kokuyeka ukuya exesheni.Ukuba usandul’ ukuya exesheni, xoxa nogqirha wakho ngolawulo lokubeleka.Musa ukusebenzisa inkqubo yokuzalwa ene-estrogen.Akwaziwa ukuba iLetrozole idlula kubisi lwebele kwaye inokwenzakalisa usana oluncancisayo.Ukuncancisa ngelixa usebenzisa iLetrozole akukhuthazwa.
Idosi ye-Letrozole/Femara yomhlaza wamabele
1:Idosi yesiqhelo yabantu abadala kuMhlaza wamabele:
Ukusetyenziswa njengonyango lokuqala lwabasetyhini abasemva kokuya exesheni abane-hormone receptor positive okanye i-hormone receptor engaziwayo ekuhlaleni okanye umhlaza wamabele we-metastatic.I-Femara iphinda iboniswe kunyango lomhlaza webele ophezulu kubasetyhini be-postmenopausal abanenkqubela phambili yesifo kulandela unyango lwe-antiestrogen: i-tablet ye-2.5 mg ilawulwa ngomlomo kanye ngosuku ngaphandle kokujonga ukutya.
Kwizigulane ezinesifo esiphezulu, unyango lwe-Letrozole kufuneka luqhubeke de kubonakale ukukhula kwe-tumor.
2:Idosi eqhelekileyo yaBadala kuMhlaza wamabele-I-Adjuvant:
Ukusetyenziswa njengonyango olwandisiweyo lwe-adjuvant yomhlaza webele wokuqala kubasetyhini be-postmenopausal abaye bafumana iminyaka emi-5 yonyango lwe-adjuvant tamoxifen: i-tablet ye-2.5 mg elawulwa ngomlomo kanye ngosuku ngaphandle kokujonga ukutya.
Elona xesha lilungileyo lonyango nge-Femara alaziwa.Unyango kufuneka lupheliswe ukuba kukho ukuphinda kwethumba.
Anti-Estrogens Series Product
| Anti-estrogen Series | |
| Tamoxifen Citrate | Inombolo yeCAS: 563.64 |
| I-Clomifene Citrate | Inombolo yeCAS: 50-41-9 |
| I-Toremifene Citrate | Inombolo yeCAS: 89778-27-8 |
| Exemestane | Inombolo yeCAS: 107868-30-4 |
| Anastrozole | Inombolo yeCAS: 120511-73-1 |
| Letrozole | Inombolo yeCAS: 112809-51-5 |
| I-Fulvestrant | Inombolo yeCAS: 129453-61-8 |
